ARWR - Arrowhead Pharmaceuticals Inc
Earnings Results

Arrowhead Pharmaceuticals Inc ( $ARWR )

Recent earnings result

  1. Arrowhead Pharmaceuticals EPS misses by $0.77, misses on revenue

Events & Presentations

Arrowhead Pharmaceuticals 2019 Year End Results

Supporting docs

  1. Listen to webcast

Top Stories (ARWR)

Events & Annual meetings

Title Date Webcast
Arrowhead Pharmaceuticals 2019 Year End Results Nov 25, 2019 4:30 PM EST webcast
American Heart Association Scientific Sessions 2019 Nov 18, 2019 PDF
North American Cystic Fibrosis Conference Oct 31, 2019 11:15 AM CDT PDF
DIA/FDA Oligonucleotide-Based Therapeutics Conference Oct 28, 2019 2:30 PM EDT PDF
Arrowhead Analyst R&D Day 2019 Oct 18, 2019 8:00 AM EDT webcast PDF

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing.

Videos about Arrowhead Pharmaceuticals Inc


The Content is made available for informational purposes only. The Content may not be complete and may be subject to change.
The Content is provided without any warranty of any kind, either express or implied.
We have collected the events here to help investors easily find the informations they need.
These are manually collected by our researchers directly from Official IR pages and not third party sources.

Recent results

Books we are reading